1. India Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Suraksha Diagnostic Limited

Suraksha Diagnostic Limited

SURAKSHA.NS
Suraksha Diagnostic LimitedIN flagNational Stock Exchange of India
291.25
INR
+1.00
- -
15.17BMarket Cap

Total Valuation

Suraksha Diagnostic Limited carries a market capitalization of 15.17B, placing it among publicly traded companies globally. Its enterprise value stands at 12.89B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap15.17B
Enterprise Value12.89B

Share Statistics

Suraksha Diagnostic Limited currently has 52.08M shares outstanding.

Shares Outstanding52.08M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Suraksha Diagnostic Limited trades at a trailing price-to-earnings ratio of 36.88. The price-to-sales ratio is 3.82, and the price-to-book ratio stands at 113.96.

PE Ratio36.88
PS Ratio3.82
PB Ratio113.96
P/TBV Ratio5.02
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Suraksha Diagnostic Limited trades at an EV/EBITDA multiple of 23.69 and an EV/FCF ratio of 145.69. The EV/Sales ratio of 4.15 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 23.69 provides insight into valuation relative to core operating earnings.

EV / Sales4.15
EV / EBITDA23.69
EV / EBIT23.69
EV / FCF145.69

Financial Position

Suraksha Diagnostic Limited maintains a current ratio of 1.05, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 53.53, indicating elevated leverage, while an interest coverage ratio of 4.33 demonstrates adequate ability to service its debt obligations.

Current Ratio1.05
Quick Ratio0.45
Debt / Equity53.53
Debt / EBITDA2.40
Interest Coverage4.33

Financial Efficiency

Suraksha Diagnostic Limited posts a return on equity of 36.79 and a return on invested capital of 11.47.

Return on Equity (ROE)36.79
Return on Assets (ROA)8.24
Return on Invested Capital (ROIC)11.47
Return on Capital Employed (ROCE)21.35
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover4.51

Taxes

Over the trailing twelve months, Suraksha Diagnostic Limited has paid 131.54M in income taxes, reflecting an effective tax rate of 29.52.

Income Tax131.54M
Effective Tax Rate29.52

Stock Price Statistics

Suraksha Diagnostic Limited's stock has declined approximately -13.21514% over the past 52 weeks. The 50-day moving average sits at 277.96, while the 200-day moving average is 286.71.

Beta (5Y)N/A
52-Week Price Change-13.21514%
50-Day Moving Average277.96
200-Day Moving Average286.71
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Suraksha Diagnostic Limited generated 3.10B in revenue and converted that into 321.87M in net income, yielding earnings per share of 6.03. EBITDA reached 544.13M, while operating income came in at 544.13M.

Revenue3.10B
Gross Profit2.74B
Operating Income544.13M
Pretax Income445.57M
Net Income321.87M
EBITDA544.13M
EBIT544.13M
Earnings Per Share (EPS)6.03

Balance Sheet

Suraksha Diagnostic Limited holds 270.37M in cash and equivalents against 1.30B in total debt, resulting in a net debt position of -14.80M. Total book value stands at 104.16M, with working capital of 29.27M providing operational flexibility.

Cash & Cash Equivalents270.37M
Total Debt1.30B
Net Debt-14.80M
Equity (Book Value)104.16M
Book Value Per Share2.00
Working Capital29.27M

Margins

Suraksha Diagnostic Limited operates with a gross margin of 88.25, reflecting its pricing power and cost economics. The operating margin of 17.53 and net profit margin of 10.37 provide insight into operational efficiency.

Gross Margin88.25
Operating Margin17.53
Pretax Margin14.35
Profit Margin10.37
EBITDA Margin17.53

Scores

Suraksha Diagnostic Limited posts an Altman Z-Score of 4.60, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.60